SNY
Price
$48.18
Change
-$0.14 (-0.29%)
Updated
Jul 8 closing price
Capitalization
122.61B
22 days until earnings call
SNYNF
Price
$96.67
Change
-$1.65 (-1.68%)
Updated
Jul 7 closing price
Capitalization
134.16B
Interact to see
Advertisement

SNY vs SNYNF

Header iconSNY vs SNYNF Comparison
Open Charts SNY vs SNYNFBanner chart's image
Sanofi ADS
Price$48.18
Change-$0.14 (-0.29%)
Volume$2.43M
Capitalization122.61B
Sanofi
Price$96.67
Change-$1.65 (-1.68%)
Volume$401.74K
Capitalization134.16B
SNY vs SNYNF Comparison Chart in %
Loading...
SNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNYNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SNY vs. SNYNF commentary
Jul 09, 2025

To understand the difference between Sanofi - ADR (SNY) vs. Sanofi (SNYNF) it is enough to know the definitions of ADR

ADR - American depositary receipt (ADR) is a certificate issued by a U.S. depositary bank representing a specified number of shares (often 1 share) of a foreign company's stock. ADRs are denominated in U.S. dollars and trade on U.S. stock markets and OTC depending on the ADRs classification.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 09, 2025
Stock price -- (SNY: $48.18 vs. SNYNF: $96.68)
Brand notoriety: SNY and SNYNF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: SNY: 110% vs. SNYNF: 824%
Market capitalization -- SNY: $122.61B vs. SNYNF: $134.16B
SNY [@Pharmaceuticals: Major] is valued at $122.61B. SNYNF’s [@Pharmaceuticals: Major] market capitalization is $134.16B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SNY’s FA Score shows that 1 FA rating(s) are green whileSNYNF’s FA Score has 1 green FA rating(s).

  • SNY’s FA Score: 1 green, 4 red.
  • SNYNF’s FA Score: 1 green, 4 red.
According to our system of comparison, both SNY and SNYNF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNY’s TA Score shows that 4 TA indicator(s) are bullish while SNYNF’s TA Score has 4 bullish TA indicator(s).

  • SNY’s TA Score: 4 bullish, 6 bearish.
  • SNYNF’s TA Score: 4 bullish, 1 bearish.
According to our system of comparison, SNYNF is a better buy in the short-term than SNY.

Price Growth

SNY (@Pharmaceuticals: Major) experienced а -1.77% price change this week, while SNYNF (@Pharmaceuticals: Major) price change was +0.14% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.67%. For the same industry, the average monthly price growth was +0.29%, and the average quarterly price growth was +8.76%.

Reported Earning Dates

SNY is expected to report earnings on Oct 24, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-0.67% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNYNF($134B) has a higher market cap than SNY($123B). SNY has higher P/E ratio than SNYNF: SNY (20.80) vs SNYNF (14.04). SNY YTD gains are higher at: 4.323 vs. SNYNF (1.656). SNYNF has higher annual earnings (EBITDA): 13.8B vs. SNY (12.6B). SNY has more cash in the bank: 8.98B vs. SNYNF (7.99B). SNY has less debt than SNYNF: SNY (18.4B) vs SNYNF (21B). SNY (46.4B) and SNYNF (46.1B) have equivalent revenues.
SNYSNYNFSNY / SNYNF
Capitalization123B134B92%
EBITDA12.6B13.8B91%
Gain YTD4.3231.656261%
P/E Ratio20.8014.04148%
Revenue46.4B46.1B101%
Total Cash8.98B7.99B112%
Total Debt18.4B21B88%
FUNDAMENTALS RATINGS
SNY vs SNYNF: Fundamental Ratings
SNY
SNYNF
OUTLOOK RATING
1..100
124
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
7
Undervalued
PROFIT vs RISK RATING
1..100
70100
SMR RATING
1..100
7575
PRICE GROWTH RATING
1..100
6062
P/E GROWTH RATING
1..100
9190
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNY's Valuation (7) in the Pharmaceuticals Major industry is in the same range as SNYNF (7) in the null industry. This means that SNY’s stock grew similarly to SNYNF’s over the last 12 months.

SNY's Profit vs Risk Rating (70) in the Pharmaceuticals Major industry is in the same range as SNYNF (100) in the null industry. This means that SNY’s stock grew similarly to SNYNF’s over the last 12 months.

SNY's SMR Rating (75) in the Pharmaceuticals Major industry is in the same range as SNYNF (75) in the null industry. This means that SNY’s stock grew similarly to SNYNF’s over the last 12 months.

SNY's Price Growth Rating (60) in the Pharmaceuticals Major industry is in the same range as SNYNF (62) in the null industry. This means that SNY’s stock grew similarly to SNYNF’s over the last 12 months.

SNYNF's P/E Growth Rating (90) in the null industry is in the same range as SNY (91) in the Pharmaceuticals Major industry. This means that SNYNF’s stock grew similarly to SNY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SNYSNYNF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
50%
Bullish Trend 1 day ago
53%
Momentum
ODDS (%)
Bullish Trend 1 day ago
58%
Bullish Trend 1 day ago
54%
MACD
ODDS (%)
Bullish Trend 1 day ago
51%
Bullish Trend 1 day ago
48%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
50%
Bullish Trend 1 day ago
51%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
42%
Bearish Trend 1 day ago
46%
Advances
ODDS (%)
Bullish Trend 8 days ago
51%
Bullish Trend 7 days ago
49%
Declines
ODDS (%)
Bearish Trend 22 days ago
49%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
64%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
42%
Bearish Trend 1 day ago
48%
View a ticker or compare two or three
Interact to see
Advertisement
SNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNYNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRAG4.500.16
+3.57%
Bragg Gaming Group
BITF1.03N/A
N/A
Bitfarms Ltd
EDSA2.05-0.01
-0.49%
Edesa Biotech
GIB103.45-0.80
-0.77%
CGI
SBSW7.47-0.46
-5.80%
Sibanye-Stillwater

SNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNY has been loosely correlated with SNYNF. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if SNY jumps, then SNYNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNY
1D Price
Change %
SNY100%
-0.29%
SNYNF - SNY
61%
Loosely correlated
N/A
GSK - SNY
53%
Loosely correlated
+0.76%
NVS - SNY
48%
Loosely correlated
-0.36%
AZN - SNY
46%
Loosely correlated
+0.56%
PFE - SNY
46%
Loosely correlated
+1.51%
More

SNYNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNYNF has been loosely correlated with SNY. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if SNYNF jumps, then SNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNYNF
1D Price
Change %
SNYNF100%
N/A
SNY - SNYNF
37%
Loosely correlated
-0.29%
NVSEF - SNYNF
24%
Poorly correlated
-0.49%
AZN - SNYNF
23%
Poorly correlated
+0.56%
JNJ - SNYNF
22%
Poorly correlated
+0.33%
NVS - SNYNF
21%
Poorly correlated
-0.36%
More